Effects of escitalopram on anxiety and respiratory responses to carbon dioxide inhalation in subjects at high risk for panic disorder: A placebo-controlled, crossover study

Journal of Clinical Psychopharmacology

Volumn 29, Issue 2, 2009, Pages 174-178

  Coryell, William ^a   Rickels, Heather ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Antidepressant; Anxiety; Carbon dioxide; Escitalopram; Panic disorder; Placebo control

Indexed keywords

CARBON DIOXIDE; ESCITALOPRAM; PLACEBO;

ADULT; ANXIETY; ARTICLE; CARBON DIOXIDE BREATHING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DRUG EFFECT; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; PANIC; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; ADULT; CARBON DIOXIDE; CITALOPRAM; CROSS-OVER STUDIES; HUMANS; MALE; PANIC DISORDER; RESPIRATION; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; YOUNG ADULT;

EID: 67649376333     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31819a8d96     Document Type: Article

References (48)

1. Gorman JM, Kent JM, Sullivan GM, et al. Neuroanatomical hypothesis of panic disorder, revisited. Am J Psychiatry. 2000;157:493-505.
2. Klein DF. False suffocation alarms, spontaneous panics and related conditions. Arch Gen Psychiatry. 1993;50:306-317.
3. Perna G, Bussi R, Allevi L, et al. Sensitivity to 35% carbon dioxide in patients with generalized anxiety disorder. J Clin Psychiatry. 1999;60:379-384.
4. 2 in patients with panic disorder. Am J Psychiatry. 1996;153:1060-1064.
5. 2-induced panic attacks: a twin study. Am J Psychiatry. 1998;155:1184-1188.
6. Nardi AE, Valenca AM, Nascimento I, et al. Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks. Psychiatry Res. 2000;94:179-184.
7. Battaglia M, Ogliari A, Harris J, et al. A genetic study of the acute anxious response to carbon dioxide stimulation in man. J Psychiatr Res. 2007;41:906-917.
8. 2) inhalation paradigm to evoke anxiety symptoms in healthy subjects. J Psychopharmacol. 2005; 19:494-503.
9. Verburg K, Pols H, de Leeuw M, et al. Reliability of the 35% carbon dioxide panic provocation challenge. Psychiatry Res. 1998;78:207-214.
10. 2 challenge test. Biol Psychiatry. 1998;43:612-615.
11. Lousberg H, Griez E, van den Hout MA. Carbon dioxide chemosensitivity in panic disorder. Acta Psychiatr Scand. 1988;77:214-218.
12. Bystritsky A, Shapiro D. Continuous physiological changes and subjective reports in panic patients: a preliminary methodological report. Biol Psychiatry. 1992;32:766-777.
13. Pine DS, Koplan JD, Papp LA, et al. Ventilatory physiology of children and adolescents with anxiety disorders. Arch Gen Psychiatry. 1998;55:123-129.
14. Gorman JM, Fyor MR, Goetz R, et al. Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry. 1988;45:31-39.
15. Pain MCF, Biddle N, Tiller JWG. Panic disorder, the ventilatory response to carbon dioxide and respiratory variables. Psychosom Med. 1988;50:541-548.
16. Papp LA, Goetz R, Cole R, et al. Hypersensitivity to carbon dioxide in panic disorder. Am J Psychiatry. 1989;146:779-781.
17. Papp LA, Martinez JM, Klein DF, et al. Rebreathing tests in panic disorder. Biol Psychiatry. 1995;38:240-245.
18. Coryell W. Hypersensitivity to carbon dioxide as a disease-specific trait marker. Biol Psychiatry. 1997;41:259-263.
19. 2 as a trait of familial panic disorder. Biol Psychiatry. 2001;49:582-587.
20. 2 inhalation in subjects at high-risk for panic disorder. J Affect Disord. 2006;92:63-70.
21. Coryell W, Dindo L, Fyer A, et al. Onset of spontaneous panic attacks: a prospective study of risk factors. Psychosom Med. 2006;68:754-757.
22. Philibert RA, Nelson JJ, Sandhu HK, et al. Association of an exonic LDHA polymorphism with altered respiratory response in probands at high risk for panic disorder. Am J Med Genet. 2003;117B:11-17.
23. Bertani A, Perna G, Arancio C, et al. Pharmacologic effect of imipramine, paroxetine and sertraline on 35% carbon dioxide hypersensitivity and panic patients: a double blind, random, placebo controlled study. J Clin Psychopharmacol. 1997;17:97-101.
24. 2 hyperactivity and short term treatment outcome. J Clin Psychopharmacol. 2002;22:300-308.
25. Perna G, Bertani A, Gabriele A, et al. Modification of 35% carbon dioxide hypersensitivity across one week of treatment with clomipramine and fluvoxamine: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol. 1997;17:173-178.
26. 2 after clomipramine treatment. Psychiatry Res. 1993;47:295-296.
27. Fishman SM, Carr DB, Beckett A, et al. Hypercapneic ventilatory response in patients with panic disorder before and after alprazolam treatment and in pre and post-menstrual women. J Psychiatry Res. 1994;28:165-170.
28. Pols H, Verburg K, Hauzer R, et al. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients. Biol Psychiatry. 1996a;40:913-917.
29. Pols H, Zandbergen J, Loof CD, et al. Attenuation of carbon dioxide induced panic after clonazepam treatment. Acta Psychiatr Scand. 1991;84:585-586.
30. 2 challenge. J Clin Psychiatry. 1996b;57:539-542.
31. Sanderson WC, Wetzler S, Asnis GM. Alprazolam blockade of CO2-provoked panic in patients with panic disorder. Am J Psychiatry. 1994;51:220-1222.
32. Perna G, Cocchi S, Bertani A, et al. Pharmacologic effect of toloxatone on reactivity to the 35% carbon dioxide challenge: a single-blind, random, placebo-controlled study. J Clin Psychopharmacol. 1994;14:414-418.
33. 2 hyperactivity and clinical symptomatology in patients with panic disorder after one week of treatment with citalopram: an open study. J Clin Psychopharmacol. 2001;21:262-267.
34. 2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study. J Clin Psychopharmacol. 2004;24:277-282.
35. Gorman JM, Browne ST, Papp LA, et al. Effect of anti-panic reatment on response to carbon dioxide. Biol Psychiatry. 1997;42:982-991.
36. Woods SW, Charney DS, Loke J, et al. Carbon dioxide sensitivity in panic anxiety. Arch Gen Psychiatry. 1986;43:900-909.
37. Stahl SM, Gergel I, Li D. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2003;64:1322-1327.
38. Mannuzza S, Fyer AJ, Klein DF, et al. Schedule for Affective Disorders and Schizophrenia-Lifetime Version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development. J Psychiatr Res. 1986;20:317-325.
39. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1978;35:837-844.
40. Mannuzza S, Fyer AJ, Endicott J, et al. Family Informant Schedule and Criteria (FISC). New York: Anxiety Disorders Clinic, New York State Psychiatric Institute; 1985.
41. Peterson RA, Heilbronner RL. The Anxiety Sensitivity Index: construct validity and factor analytic structure. J Anxiety Disord. 1980; 1:117-121.
42. Beck AT, Ward CH, Mondelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
43. Beck AT, Steer RA. Manual Beck Anxiety Inventory. San Antonio, TX: The Psychological Corporation, Harcourt; 1990.
44. Spielberger CD, Gorsuch RL, Luchone RE. Manual for the State-Trait Anxiety Inventory. Revised ed. Palo Alto, CA: Consulting Psychologists Press; 1983.
45. Spielberger CD, Krasner SS. The assessment of state and trait anxiety. In: Noyes R Jr, Roth M, Burrows GD, eds. Handbook of Anxiety: Classification, Etiological Factors and Associated Disturbances. Vol 2. Amsterdam: Elsevier Science Publishers; 1988:31-51.
46. Beck AT, Epstein N, Brown G, et al. Beck Anxiety Inventory (BAI). In: Rush AJ Jr, First D, Michael B, Blacker, Deborah, eds. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Publishing, Inc; 2008:537.
47. 2 in healthy first-degree relatives of patients with panic disorder. Am J Psychiatry. 1995;152:623-625.
48. 2 challenge in healthy first-degree relatives of patients with panic disorder. Biol Psychiatry. 2000;47:830-835.